Schedule 13G ownership disclosure

SUTRO BIOPHARMA INC

Security class unavailable · CUSIP: 869367102

Event date: 2018-09-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,723,509
Percent of class
11.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-060573
Form type
SC 13G
Filer
Merck & Co., Inc.
CIK
CIK 310158
Filed
Oct 04, 2018
Reporting period
Sep 26, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub